The progenotoxic (G, generation of reactive oxygen forms in mononuclears) and hormonal (H, reactive insulinemia) effects of oral glucose, on the one hand, and the same effects of estradiol (10–8 and 10–5 M) in vitro on blood mononuclears (G: by comet tail length; H: by expression of AMP kinase and TNF and IL-6 secretion), on the other, were compared with consideration for the concepts on endocrine genotoxic switch-over in patients with breast cancer and endometrial cancer in remission. Coculturing of mononuclears with estradiol in general led to an increase in comet tail and was associated with a trend to more intense expression of AMP kinase and IL-6 secretion. The reaction to estradiol (primarily in a concentration of 10–8 M) evaluated by the expression of AMP kinase and TNF secretion was more intensive than the reaction evaluated by comet tail lengths or by percentage of cells with comets in women with predominating progenotoxic effect of glucose vs. hormonal effect. This fact can be used as a landmark in search for means for optimization of the status and proportion of effects in the estrogen and glucose systems.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
L. M. Berstein, Oncoendocrinology [in Russian], St. Petersburg (2004).
L. M. Berstein, E. V. Tsyrlina, A. Yu. Kovalevskii, et al., Vestn. Rossiisk. Akad. Med. Nauk, No. 1, 12-18 (2008).
D. A.Vasil’yev, T. E. Poroshina, I. G. Kovalenko, et al., Uspekhi Gerontol., 21, No. 2, 204-211 (2008).
N. E. Kushlinskii, S. M. Portnoi, and K. P. Laktionov, Breast Cancer [in Russian], Moscow (2005).
K. Asai, N. Hiki, Y. Mimura, et al., Shock, 16, No. 5, 340-343 (2001).
L. M. Berstein, D. A. Vasilyev, T. E. Poroshina, and I. G. Kovalenko, Horm. Metab. Res., 38, No. 10, 650-655 (2006).
E. Cavalieri and E. Rogan, Ann. N. Y. Acad. Sci., 1089, 286- 301 (2006).
P. Dandona, K. Thusu, R. Hafeez, et al., Metabolism, 47, No. 7, 788-791 (1998).
T. M. D’Eon, N. H. Rogers, Z. S. Stancheva, and A. S. Greenberg, Obesity, 16, No. 6, 1284-1288 (2008).
W. R. Miller, Estrogen and Breast Cancer, Austin, TX, Landes Bioscience (1996).
H. Moir, L. Butcher, K. P. Jones, et al., Appl. Physiol. Nutr. Metab., 33, No. 1, 75-85 (2008).
S. M. Piperakis, E. Petrakou, S. Tsilimigaki, et al., Environ. Mol. Mutagen, 41, No. 2, 104-110 (2003).
K. U. Schallreuter, G. Chiuchiarelli, E. Cemeli, et al., J. Invest. Dermatol., 126, No. 5, 1036-1042 (2006).
W. Shen, Z. Chen, W. Shou, and E. Liechty, FASEB J., 21, 746-747 (2007).
W. Yue, R. J. Santen, J. P. Wang, et al., J. Steroid Biochem. Mol. Biol., 86, Nos. 3-5, 477-486 (2003)
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 150, No. 8, pp. 208-211, August, 2010
Rights and permissions
About this article
Cite this article
Berstein, L.M., Poroshina, T.E., Vasilyev, D.A. et al. Evaluation of the Proportion of Hormonal and Progenotoxic Effects of Estrogens and Glucose in Cancer Patients. Bull Exp Biol Med 150, 243–246 (2010). https://doi.org/10.1007/s10517-010-1115-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-010-1115-9